Literature DB >> 24913070

Dexmedetomidine: a review of applications for cardiac surgery during perioperative period.

Xiaoyu Zhang1, Xuan Zhao, Yingwei Wang.   

Abstract

Cardiac surgery is associated with a high incidence of cardiovascular and other complications during the perioperative period that translate into increased mortality and prolonged hospital stays. Safe comprehensive perioperative management is required to eliminate these adverse events. Dexmedetomidine is a selective α2-adrenoreceptor agonist that has been described as an ideal medication in the perioperative period of cardiac surgery. The major clinical effects of dexmedetomidine in this perioperative period can be summarized as attenuating the hemodynamic response, cardioprotective effects, antiarrhythmic effects, sedation in the ICU setting, treatment of delirium, and procedural sedation. Although there are some side effects of dexmedetomidine, it is emerging as an effective therapeutic agent in the management of a wide range of clinical conditions with an efficacious, safe profile. The present review serves as an overview update in the diverse applications of dexmedetomidine for cardiac surgery during the perioperative period.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24913070     DOI: 10.1007/s00540-014-1857-z

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  83 in total

1.  Preoperative predictors of delirium after cardiac surgery: a preliminary study.

Authors:  Jakub Kazmierski; Maciej Kowman; Maciej Banach; Tomasz Pawelczyk; Piotr Okonski; Alicja Iwaszkiewicz; Janusz Zaslonka; Tomasz Sobow; Iwona Kloszewska
Journal:  Gen Hosp Psychiatry       Date:  2006 Nov-Dec       Impact factor: 3.238

Review 2.  Dextromethorphan and dexmedetomidine: new agents for the control of perioperative pain.

Authors:  A A Weinbroum; R Ben-Abraham
Journal:  Eur J Surg       Date:  2001-08

3.  The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children.

Authors:  Julia C Finkel; Yewande J Johnson; Zenaide M N Quezado
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

4.  [The effect of dexmedetomidine in a child with intractable supraventricular tachyarrythmia after total cavopulmonary connection].

Authors:  Eriko Ohsugi; Yusuke Nagamine; Masahide Ohtsuka
Journal:  Masui       Date:  2011-04

5.  Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study).

Authors:  Yahya Shehabi; Peter Grant; Hugh Wolfenden; Naomi Hammond; Frances Bass; Michelle Campbell; Jack Chen
Journal:  Anesthesiology       Date:  2009-11       Impact factor: 7.892

6.  Incidence and precipitating factors of delirium after coronary artery bypass grafting.

Authors:  Ieva Norkiene; Donata Ringaitiene; Irina Misiuriene; Robertas Samalavicius; Rimas Bubulis; Alis Baublys; Giedrius Uzdavinys
Journal:  Scand Cardiovasc J       Date:  2007-06       Impact factor: 1.589

7.  Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.

Authors:  Erin N Frazee; Heather A Personett; Jonathan G Leung; Sarah Nelson; Ross A Dierkhising; Philippe R Bauer
Journal:  J Crit Care       Date:  2013-11-23       Impact factor: 3.425

8.  Prevalence and risk factors for postoperative delirium in a cardiovascular intensive care unit.

Authors:  Yu-Ling Chang; Yun-Fang Tsai; Pyng-Jing Lin; Min-Chi Chen; Chia-Yih Liu
Journal:  Am J Crit Care       Date:  2008-11       Impact factor: 2.228

9.  Does dexmedetomidine provide cardioprotection in coronary artery bypass grafting with cardiopulmonary bypass? A pilot study.

Authors:  Zeynep Tosun; Mehmet Baktir; Husnu Cemal Kahraman; Gulden Baskol; Gulen Guler; Adem Boyaci
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-05-30       Impact factor: 2.628

10.  Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery.

Authors:  James L Rudolph; Richard N Jones; Sue E Levkoff; Christopher Rockett; Sharon K Inouye; Frank W Sellke; Shukri F Khuri; Lewis A Lipsitz; Basel Ramlawi; Sidney Levitsky; Edward R Marcantonio
Journal:  Circulation       Date:  2008-12-31       Impact factor: 29.690

View more
  12 in total

1.  Effects of dexmedetomidine on cellular immunity of perioperative period in children with brain neoplasms.

Authors:  Lei Wu; Haoxuan Lv; Wenjie Luo; Shu Jin; Yannan Hang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Is postoperative delirium a relevant outcome?

Authors:  Moritoki Egi
Journal:  J Anesth       Date:  2015-05-23       Impact factor: 2.078

3.  Effects of dexmedetomidine on the expression of inflammatory factors in children with congenital heart disease undergoing intraoperative cardiopulmonary bypass: a randomized controlled trial.

Authors:  Yongsheng Qiu; Chan Li; Xiaoqin Li; Yingping Jia
Journal:  Pediatr Investig       Date:  2020-03-17

4.  The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery.

Authors:  Rabie Soliman; Gomaa Zohry
Journal:  Ann Card Anaesth       Date:  2016 Oct-Dec

Review 5.  Neuroprotective Anesthesia Regimen and Intensive Management for Pediatric Cardiac Surgery with Cardiopulmonary Bypass: a Review and Initial Experience.

Authors:  Jyrson Guilherme Klamt; Walter Villela de Andrade Vicente; Luis Vicente Garcia; Fabio Carmona; João Abrão; Antônio Carlos Menardi; Paulo Henrique Manso
Journal:  Braz J Cardiovasc Surg       Date:  2017 Nov-Dec

6.  Safety and efficacy of ketamine-dexmedetomidine versus ketamine-propofol combinations for sedation in patients after coronary artery bypass graft surgery.

Authors:  Mona Mohamed Mogahd; Mohammed Shafik Mahran; Ghada Foad Elbaradi
Journal:  Ann Card Anaesth       Date:  2017 Apr-Jun

7.  Pre-cardiopulmonary bypass administration of dexmedetomidine decreases cardiac troponin I level following cardiac surgery with sevoflurane postconditioning.

Authors:  Hong-Mei Zhou; Xiao-Yan Ling; Yun-Jian Ni; Cheng Wu; Zhi-Peng Zhu
Journal:  J Int Med Res       Date:  2019-06-24       Impact factor: 1.671

8.  Is It Time for an Expanded Role of Dexmedetomidine in Contemporary Anesthesia Practice? - A Clinician's Perspective.

Authors:  Christian Bohringer; Hong Liu
Journal:  Transl Perioper Pain Med       Date:  2018-04-12

9.  A comparison of the outcomes of dexmedetomidine and remifentanil with sufentanil-based general anesthesia in pediatric patients for the transthoracic device closure of ventricular septal defects.

Authors:  Ling-Shan Yu; Wen-Peng Xie; Jian-Feng Liu; Jing Wang; Hua Cao; Zeng-Chun Wang; Qiang Chen
Journal:  J Cardiothorac Surg       Date:  2021-04-23       Impact factor: 1.637

10.  Myocardial protective effects of dexmedetomidine in patients undergoing cardiac surgery: A meta-analysis and systematic review.

Authors:  Zheng Gong; Li Ma; Yu-Lin Zhong; Jun Li; Jing Lv; Yu-Bo Xie
Journal:  Exp Ther Med       Date:  2017-03-13       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.